Get started
Author

Xuying Pei

Observed names: XiaoJun Huang, Xu-Ying Pei, Xu-ying Pei, Xu‐Ying Pei
ORCID: 0000-0003-1200-7763
Observed ORCID: 0000-0003-1200-7763
OpenAlex ID: A5022860071
Cytomegalovirus-Specific T-Cell Transfer for Refractory Cytomegalovirus Infection After Haploidentical Stem Cell Transplantation: The Quantitative and Qualitative Immune Recovery for Cytomegalovirus
2017 · Xu-Ying Pei, Xiang-Yu Zhao, et al. · The Journal of Infectious Diseases · 104
PDF
Haematopoietic stem-cell transplantation in China in the era of targeted therapies: current advances, challenges, and future directions
2022 · Ying-Jun Chang, Xu-Ying Pei, et al. · The Lancet Haematology · 92
Invasive fungal infection in allogeneic hematopoietic stem cell transplant recipients: single center experiences of 12 years
2015 · Ji-min Shi, Xu-ying Pei, et al. · Journal of Zhejiang University SCIENCE B · 51
PDF
First-line Therapy With Donor-derived Human Cytomegalovirus (HCMV)–specific T Cells Reduces Persistent HCMV Infection by Promoting Antiviral Immunity After Allogenic Stem Cell Transplantation
2019 · Xiang-Yu Zhao, Xu-Ying Pei, et al. · Clinical Infectious Diseases · 44
Adoptive therapy with cytomegalovirus ‐specific T cells for cytomegalovirus infection after haploidentical stem cell transplantation and factors affecting efficacy
2022 · Xu‐Ying Pei, Xiang‐Yu Zhao, et al. · American Journal of Hematology · 38
Comparable anti-CMV responses of transplant donor and third-party CMV-specific T cells for treatment of CMV infection after allogeneic stem cell transplantation
2021 · Xu-Ying Pei, Xue-Fei Liu, et al. · Cellular and Molecular Immunology · 30
Donor-Specific Anti-Human Leukocyte Antigen Antibodies Predict Prolonged Isolated Thrombocytopenia and Inferior Outcomes of Haploidentical Hematopoietic Stem Cell Transplantation
2017 · Xiaosu Zhao, Xiangyu Zhao, et al. · Journal of Immunology Research · 27
PDF
HLA haploidentical HSCT: from immune imbalance to a platform for immune homeostasis restoration
2025 · Huidong Guo, Zheng-Li Xu, et al. · Immunity & Inflammation · 22
PDF
Donor NKG2C homozygosity contributes to CMV clearance after haploidentical transplantation
2022 · Xing-Xing Yu, Qian-Nan Shang, et al. · JCI Insight · 17
PDF
New approaches in allogenic transplantation in AML
2018 · Xuying Pei, Xiaojun Huang · Seminars in Hematology · 16
Letermovir prophylaxis for cytomegalovirus is associated with risk of post-transplant lymphoproliferative disorders after haploidentical stem cell transplantation
2024 · Xu-Ying Pei, Qiang Huang, et al. · Haematologica · 15
PDF
Impact of HLA allele mismatch at HLA-A, -B, -C, -DRB1, and -DQB1 on outcomes in haploidentical stem cell transplantation
2018 · Ming-Rui Huo, Xu-Ying Pei, et al. · Bone Marrow Transplantation · 15
Comparison of reference values for immune recovery between event-free patients receiving haploidentical allografts and those receiving human leukocyte antigen-matched sibling donor allografts
2017 · Xuying Pei, Xiangyu Zhao, et al. · Frontiers of Medicine · 13
The role of immune reconstitution in relapse after allogeneic hematopoietic stem cell transplantation
2024 · Xu-Ying Pei, Xiao-Jun Huang · Expert Review of Clinical Immunology · 7
Homoharringtonine suppresses acute myeloid leukemia progression by orchestrating EWSR1 phase separation in an m 6 A‐YTHDF2‐dependent mechanism
2025 · Ting‐Ting Liu, Li‐Ting Chen, et al. · iMeta · 6
Targeting early EBV-driven IDO1-NAD metabolism as a potential therapeutic strategy for EBV-related diseases
2024 · Ling-Jie Luo, Xu-Ying Pei, et al. · The Innovation Medicine · 6
PDF
Immune Reconstitution of Patients Who Recovered From Steroid-Refractory Acute Graft-Versus-Host Disease After Basiliximab Treatment
2022 · Dao-Xing Deng, Shuang Fan, et al. · Frontiers in Oncology · 6
PDF
Optimization of T-cell-replete haploidentical hematopoietic stem cell transplantation: the Chinese experience
2024 · Xiaodong Mo, Xuying Pei, et al. · Haematologica · 4
PDF
Clinical manifestations and outcomes of EBV-related secondary hemophagocytic lymphohistiocytosis
2025 · Dan Liu, Xuying Pei, et al. · Annals of Hematology · 3
PDF
Long-term efficacy of CMV/EBV bivirus-specific T cells for viral co-reactivation after stem cell transplantation
2025 · Xuying Pei, Meng Lv, et al. · Chinese Medical Journal · 3
Long-Term Efficacy of Epstein-Barr Virus-Specific T Cells for Epstein-Barr Virus-Associated Post-Transplantation Lymphoproliferative Disorder after Allogeneic Stem Cell Transplantation: A Real-World Study
2025 · Hai-Lu Sun, Qiang Fu, et al. · Transplantation and Cellular Therapy · 2
Virus-Specific CD8+ Stem Memory T Lymphocytes Display Enhanced Anti-Virus Responses
2023 · Xunhong Cao, Xuying Pei, et al. · Blood · 2
Comparison of Safety and Efficacy between Venetoclax Combined with CAG (cytarabine, aclarubicin, G-CSF) Regimen and CAG Regimen Alone in Patients with Relapsed or Refractory Acute Myeloid Leukemia
2023 · Wen-Jing Yu, Ying Wu, et al. · Blood · 2
PDF
Blinatumomab exposure prior to allogeneic stem cell transplantation is associated with increased Epstein-Barr virus reactivation
2026 · Hai-Lu Sun, Zhi-Fan Zhao, et al. · Annals of Hematology · 1
PDF
Comparison of Transplant Donor and Third-Party Donor Derived CMV-Specific T Cells for CMV Infection after Allogenic Stem Cell Transplantation
2021 · Xuying Pei, Xuefei Liu, et al. · Blood · 1
Works count: 48
Citation count: 528
H-index: 13
I10-index: 13
Year
Topic
Type